Ysbyty Gwynedd MDT

The Ysbyty Gwynedd MDT incorporates Ysbyty Gwynedd in Bangor http://www.wales.nhs.uk/sitesplus/861/home

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Advanced disease services:
    • Distal sacrectomy
  • Support service facilities:
    • Availability of 24 hour palliative care advice

Data Quality
All Patients: Trust Network National
Number of patients in Audit 197 2335 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 93 96 86
– Performance status (%) 99 98 89
Patients having major resection: Trust Network National
Number of patients in Audit 138 1436 19631
ASA grade 1 (%) 1 6 9
ASA grade 2 (%) 46 49 53
ASA grade 3 (%) 47 37 31
ASA grade 4+ (%) 6 7 2
ASA grade not recorded (%) N/A 1 4
Data completeness of:
7 Audit items for risk-adjustment (%) 99 95 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients
All Patients: Trust Network National
Number of patients in Audit 197 2335 35779
Seen by Clinical Nurse Specialist (%) 92 88 88

Management of patients having major resection
Patients having major resection: Trust Network National
Number of patients in Audit 138 1436 19614
Distant metastases (%) 9 8 5
Urgent or emergency surgery (%) 21 18 15
At least 12 lymph nodes excised (%) 93 89 84
Laparoscopic surgery attempted (%) 59 65 72
Risk-adjusted length of stay > 5 days (%) 75 60 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 71 N/A 10747
Adjuvant chemotherapy (%) 65 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 45 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 28 N/A 22

Rectal cancer patients
Patients having major resection: Trust Network National
Number of patients in Audit 33 N/A 4251
Neoadjuvant therapy (%) 36 N/A 33
Circumferential resection margin: Recorded (%) 94 91 89
Circumferential resection margin: Negative (%) 94 86 83
Rectal volume 36 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 97 1145 19644
APER/Hartmanns (%) 46 45 37

Compare trust outcomes

Copyright © 2024 National Bowel Cancer Audit | Lovingly Crafted by Mixd